Mirus Bio Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

Mirus Bio General Information

Description

Provider of gene transfer technologies intended to serve the pharmaceutical industry. The company focuses on the discovery and development of innovative nucleic acid-based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform, thereby offering life scientists with advanced tools for gene expression, biotherapeutic protein production, virus manufacturing and genome editing.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 5602 Research Park Boulevard
  • Suite 210
  • Madison, WI 53719
  • United States
Primary Industry
Biotechnology
Other Industries
Distributors (Healthcare)
Parent Company
Vertical(s)
Corporate Office
  • 5602 Research Park Boulevard
  • Suite 210
  • Madison, WI 53719
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mirus Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Mirus Bio‘s full profile, request access.

Request a free trial

Mirus Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of gene transfer technologies intended to serve the pharmaceutical industry. The company focuses on the discove
Biotechnology
Madison, WI
60 As of 2025

Seoul, South Korea
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mirus Bio Competitors (44)

One of Mirus Bio’s 44 competitors is ToolGen, a Formerly VC-backed company based in Seoul, South Korea.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ToolGen Formerly VC-backed Seoul, South Korea
Editas Medicine Formerly VC-backed Cambridge, MA
Regenxbio Formerly VC-backed Rockville, MD
Cytovance Biologics Formerly PE-Backed Oklahoma City, OK
Horizon Discovery Formerly VC-backed Cambridge, United Kingdom
You’re viewing 5 of 44 competitors. Get the full list »

Mirus Bio Patents

Mirus Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026117673-A1 Transfection compositions comprising cationic polymers, cationic lipids, and stabilizing agents Pending 30-Nov-2024
WO-2026076376-A1 Transfection reagent comprising cationic polymer and amphipathic compound Pending 06-Oct-2024
JP-2026517819-A Small molecule enhancer for adeno-associated virus production Pending 02-May-2023
AU-2024265723-A1 Small molecule enhancers for adeno-associated virus production Pending 02-May-2023
EP-4705491-A2 Small molecule enhancers for adeno-associated virus production Pending 02-May-2023 C12N15/86
To view Mirus Bio’s complete patent history, request access »

Mirus Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mirus Bio Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Mirus Bio‘s full profile, request access.

Request a free trial

Mirus Bio FAQs

  • When was Mirus Bio founded?

    Mirus Bio was founded in 1995.

  • Where is Mirus Bio headquartered?

    Mirus Bio is headquartered in Madison, WI.

  • What is the size of Mirus Bio?

    Mirus Bio has 60 total employees.

  • What industry is Mirus Bio in?

    Mirus Bio’s primary industry is Biotechnology.

  • Is Mirus Bio a private or public company?

    Mirus Bio is a Private company.

  • What is the current valuation of Mirus Bio?

    The current valuation of Mirus Bio is .

  • What is Mirus Bio’s current revenue?

    The current revenue for Mirus Bio is .

  • Who are Mirus Bio’s investors?

    Gamma Biosciences and Roche have invested in Mirus Bio.

  • Who are Mirus Bio’s competitors?

    ToolGen, Editas Medicine, Regenxbio, Cytovance Biologics, and Horizon Discovery are some of the 44 competitors of Mirus Bio.

  • When was Mirus Bio acquired?

    Mirus Bio was acquired on 31-Jul-2024.

  • Who acquired Mirus Bio?

    Mirus Bio was acquired by Merck.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process